Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1361
| Despition | PAX2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1542 | Human GSK3B Protein , sf9 (AC1542) | 2 µg | inquiry |
| ACPP-1502 | Human DAG1 Protein (AC1502) | 2 µg | inquiry |
| ACPP-1267 | Acrp30 Mouse, Trimeric (AC1267) | 2 µg | inquiry |
| ACPP-1847 | Human GFRA3 Protein (AC1847) | 5 µg | inquiry |
| ACPP-1244 | SOX2 Blocking Peptide (AC1244) | 250 µg | inquiry |
| ACPP-1692 | Human GLUL Protein (AC1692) | 5 µg | inquiry |
| ACPP-1354 | PAX2 Blocking Peptide (AC1354) | 250 µg | inquiry |
| ACPP-1605 | Human PNMT Protein (AC1605) | 5 µg | inquiry |
| ACPP-1311 | Human LIF Protein (AC1311) | 3 x 2 µg | inquiry |
| ACPP-1465 | Human CHRNA3 Protein (AC1465) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.